Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse] 송영두 2025.04.03 오전 08:08 CKD Bio, Botulinum Toxin Receives Domestic Approval[K-bio Pulse] 김지완 2025.04.02 오전 07:30 Biotech Stocks Rise on Clinical Trial Hopes[K-bio Pulse] 김승권 2025.04.01 오전 08:09 Aptabio Rallies on Gilead Comparison, Bukwang Drops on $75M Share Sale[K-Bio Pulse] 송영두 2025.03.31 오전 07:40 'Drug Technology Transfer' Bridge Bio·HLB Therapeutics Stocks Surge[K-Bio Pulse] 신민준 2025.03.28 오전 07:40 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 OliPass hits upper limit amid ownership shuffle, NatureCell soars on FDA ‘BTD’[K-Bio Pulse] 임정요 2025.03.26 오전 07:59 HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse] 나은경 2025.03.25 오전 07:49 HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse] 김진수 2025.03.24 오전 08:00 Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse] 김새미 2025.03.21 오전 08:00 더 보기 로딩중..
K-bioPulse
K-bioPulse
![Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040300289b.jpg)
![CKD Bio, Botulinum Toxin Receives Domestic Approval[K-bio Pulse]](https://image.edaily.co.kr/images/photo/files/NP/S/2025/04/PS25040200217b.jpg)
![Biotech Stocks Rise on Clinical Trial Hopes[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040100391b.jpg)
![Aptabio Rallies on Gilead Comparison, Bukwang Drops on $75M Share Sale[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25033100100b.jpg)
!['Drug Technology Transfer' Bridge Bio·HLB Therapeutics Stocks Surge[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032800273b.jpg)
![CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032700436b.jpg)
![OliPass hits upper limit amid ownership shuffle, NatureCell soars on FDA ‘BTD’[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032600293b.jpg)
![HLB Rebounds After CRL, Eyes FDA Decision by July[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032500216b.jpg)
![HLB Group Stocks Plunge After FDA Rejects Liver Cancer Drug Approval Again[K-Bio Pulse]](https://image.edaily.co.kr/images/photo/files/NP/S/2025/03/PS25032400143b.jpg)
![Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032100275b.jpg)